SCHEMBL22987140

SCHEMBL22987140

CCC(CC)(NC(=O)c1ccc(N)cc1)C(=O)O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.49
MAPT P10636 1/20 0.49
HIF1A Q16665 1/20 0.49
SLC22A6 Q4U2R8 1/20 0.49
SLC22A8 Q8TCC7 1/20 0.49
LMNA P02545 5/20 0.45
SLC22A2 O15244 1/20 0.45
SLC22A1 O15245 1/20 0.45
ALDH1A1 P00352 1/20 0.45
TSHR P16473 1/20 0.45
ACHE P22303 1/20 0.45
MAPK1 P28482 1/20 0.45
CYP2C19 P33261 1/20 0.45
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
POLB P06746 2/20 0.44
PKM P14618 1/20 0.44
APEX1 P27695 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
EPHX2 P34913 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3935814 0.85 MEN1 (0.44) KDM4EMAPTHIF1ASLC22A6SLC22A8
SCHEMBL3935810 0.85 MEN1 (0.44) KDM4EMAPTHIF1ASLC22A6SLC22A8
SCHEMBL22987109 0.84 NPC1 (0.44) KDM4EMAPTHIF1ASLC22A6SLC22A8
SCHEMBL22987071 0.80 ESR1 (0.40) KDM4EMAPTALDH1A1MEN1KMT2A
SCHEMBL5940572 0.79 HTT (0.52) KDM4EMAPTHIF1ASLC22A6SLC22A8
SCHEMBL9659950 0.79 KDM4E (0.47) KDM4EMAPTHIF1ASLC22A6SLC22A8
SCHEMBL22987134 0.78 KDM4E (0.34) KDM4EMAPTALDH1A1TSHRCYP2C19
SCHEMBL3927036 0.78 POLB (0.47) KDM4EMAPTHIF1ALMNAALDH1A1
SCHEMBL3927037 0.78 POLB (0.47) KDM4EMAPTHIF1ALMNAALDH1A1
SCHEMBL22987120 0.77 MAPT (0.49) KDM4EMAPTHIF1ASLC22A6SLC22A8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3586838-B1 AMIDE DERIVATIVE DAIICHI SANKYO CO LTD (JP) 2021-10-27 EP disclosed
EP-3586838-B1 AMIDE DERIVATIVE DAIICHI SANKYO CO LTD (JP) 2021-10-27 EP disclosed
US-10925848-B2 Amide derivative DAIICHI SANKYO COMPANY, LIMITED (JP) 2021-02-23 US disclosed
US-10925848-B2 Amide derivative DAIICHI SANKYO COMPANY, LIMITED (JP) 2021-02-23 US disclosed
CN-110325184-A Amide derivatives 第一三共株式会社 2019-10-11 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10925848-B2 Amide derivative IDO1, IDO2, TPH1 KDM4E 2941/4885MAPT 4144/4885HIF1A 3051/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.